[HTML][HTML] Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD

S Stasik, M Kramer, S Zukunft, C Röllig… - Frontiers in …, 2022 - frontiersin.org
FLT3-ITD mutations are common druggable alterations in patients with acute myeloid
leukemia (AML) and associated with poor prognosis. Beside typical ITD mutations, point …

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD

S Stasik, M Kramer, S Zukunft, C Röllig… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
FLT3-ITD mutations are common druggable alterations in patients with acute myeloid
leukemia (AML) and associated with poor prognosis. Beside typical ITD mutations, point …

[HTML][HTML] Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD

S Stasik, M Kramer, S Zukunft, C Röllig… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
FLT3-ITD mutations are common druggable alterations in patients with acute myeloid
leukemia (AML) and associated with poor prognosis. Beside typical ITD mutations, point …

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD.

S Stasik, M Kramer, S Zukunft, C Röllig… - Frontiers in …, 2022 - europepmc.org
FLT3-ITD mutations are common druggable alterations in patients with acute myeloid
leukemia (AML) and associated with poor prognosis. Beside typical ITD mutations, point …

Point Mutations in the FLT3-ITD Region Are Rare but Recurrent Alterations in Adult AML and Associated With Concomitant KMT2A-PTD.

S Stasik, M Kramer, S Zukunft, C Röllig… - Frontiers in …, 2022 - europepmc.org
FLT3-ITD mutations are common druggable alterations in patients with acute myeloid
leukemia (AML) and associated with poor prognosis. Beside typical ITD mutations, point …